Patient characteristic stratified by response to treatment.
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
官方服务：
资源简介：
Patient characteristic stratified by response to treatment.
应用场景：
创建时间：
2014-11-07
相关数据集
Table_4_TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer.XLS
TP53 mutation is a critical driver mutation that affects the carcinogenesis and prognosis of patients with pancreatic cancer (PC). Currently, there is no driver mutation-derived signature based on TP5
NIAID Data Ecosystem70
Variability of the metabolomic profiles in terms of potential confounding variables in the four principal components identified by PCA and expressed as F-values together with the corresponding p-values (in brackets).
ANOVA test, significant values (p<0.05) are in bold. Smoking, co-morbidity, ACPA and RF variables are defined as presence or absence; dietary habits variable is defined as mediterranean diet or non-me
NIAID Data Ecosystem30
DataSheet_1_The predictive and prognostic role of metabolic and volume-based parameters of positron emission tomography/computed tomography as non-invasive dynamic biological markers in early breast cancer treated with preoperative systemic therapy.pdf
IntroductionThe role of fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in early breast cancer treated with preoperative systemic therapy (PST) is not yet establishe
NIAID Data Ecosystem20
A new epithelial cell subpopulation predicts response to surgery, chemotherapy, and immunotherapy in bladder cancer. A new epithelial cell subpopulation predicts response to surgery, chemotherapy, and immunotherapy in bladder cancer
The advent of neoadjuvant chemotherapy (NAC) prior to surgery and immune checkpoint therapy (ICT) have revolutionized bladder cancer management1-7. However, stratification of patients that would benef
NIAID Data Ecosystem30
Gene expression is associated with change in disease activity measured by DCE-MRI.
(A) High signature score correlates with Ktrans improvement in the treatment arm and Ktrans deterioration in the placebo arm. Scatter plots show baseline and treatment adjusted 14-week change in log K
Figshare2016-02-23 更新30
